Purpose To describe the clinical profile of idiopathic optic neuritis in South African blacks.
Results Eighteen eyes of 10 patients were studied. The mean age was 35.7 years and 9 patients were female. Only 2 patients had truly unilateral optic neuritis, the other 8 
Conclusion Idiopathic optic neuritis in black
South Africans differs from that in whites.
The higher prevalence of bilateral cases and of · optic disc swelling, the weaker association with MS and the extremely poor visual outcome distinguish optic neuritis in black South Africans. severe visual loss as well as significant non ophthalmic neurological deficit. African Americans with demyelinating optic neuritis had more severly affected visual acuities at onset and after 1 year follow-up compared with white patients. 3 The Optic Neuritis Treatment Trial (ONTT) included 59 African-American patients whose 6 month visual acuities did not differ significantly from those of white aNTI patients. 3 . 4 In light of the small number of black patients with idiopathic optic neuritis studied and the conflicting reports on African-American patients, we undertook this pilot study to describe the clinical profile of acute isolated idiopathic optic neuritis in the urban black community which our medical centre serves.
Patients and methods
Baragwanath Chris Hani Hospital and its affiliated St John's Eye Hospital of Johannesburg (Soweto), South Africa serve a regional urban population of almost 3 million. Cases of optic neuropathy managed in this institution between January and July 1999 were referred to R.P. for neuro-ophthalmological assessment and follow-up.
The diagnosis of acute optic neuritis required the following criteria: visual loss which progressed over 2 or more days and reached peak visual deficit within 14 days, dyschromatopsia and decreased pupillary light reaction. Exclusion criteria were suspicion of Leber's hereditary optic neuropathy on the basis of a positive family history or fundal appearance, toxin or drug exposure, uveitis, vascular disease such as vasculitis or ischaemic optic neuropathy (ION), neurosyphilis diagnosed on the basis of positive serology and active cerebrospinal fluid (CSF), positive human immunodeficiency virus (HIV) type-1 serology, other neurological deficit such as cranial nerve palsies or myelopathy, or any race other than South African black.
From 26 consecutive cases of optic neuropathy, 20 were diagnosed as. acute optic neuritis (initial episode or recurrent). Three of these patients had neurosyphilis, 4 were found to be HIV-seropositive, 2 had associated cranial nerve palsies, 1 had a transverse myelitis (and CSF manometry and evaluation for protein, cells, syphilis, tuberculosis and fungal infections were performed in all cases. The presence of oligoclonal banding in the IgG region was assessed by protein electrophoresis in 6 of the 10 study CSFs.
Brain and orbit computed tomography (CT) with contrast injection (Omnipaque, Schering, Germany) was performed in all patients. Four patients underwent brain and orbit magnetic resonance imaging (MRI), which included T2-weighted and/or fluid-attenuated inverted inversion recovery (FLAIR) sequences. Fundal fluorescein angiography was performed in 2 patients in whom anterior ION was considered a possibility (patients over 45 years with marked unilateral optic disc swelling).
Patients were treated with intravenous methylprednisolone 1000 mg/ day for 3-5 days followed by oral prednisone 1 mg/kg/day to complete the 14 day treatment course, or with oral prednisone 1 mg/kg/ day alone for 14 days. Following one of these treatment protocols, steroids were tapered rapidly.
Results
No patient presenting with the above clinical definition of acute isolated optic neuritis was excluded on the basis of pre-existing multiple sclerosis (MS). Eighteen eyes of 1 male and 9 female patients with acute isolated idiopathic optic neuritis were studied. Their clinical features at presentation are summarised in Table 1 . Six patients had a single episode of optic neuritis and 4 had recurrent disease. Four were bilaterally simultaneous (BS), 3 bilaterally consecutive (BC), 1 both BS and BC, and 2 unilateral.
Mean age was 35.7 years for the entire group, 35.3 years for the first-episode group and 36.3 years for the recurrent group. All patients, except patient 9, had periocular pain exacerbated by eye movement. This pain resolved in all patients on follow-up.
Presenting V A was less than 6/60 in all except 1 study eye. Presenting colour vision was also poor -all 18 eyes failed to read the Ishihara 12 test plate, although 7 eyes 'Follow-up of the currently affected eye; total patient follow-up from the first episode is shown in parentheses.
were able to differentiate large red and green discs. All patients, except 2 of the recurrent group, had some degree of optic disc swelling of the affected eye. This varied from mild localised peripapillary nerve fibre layer swelling with mild disc hyperaemia to a markedly swollen raised disc with blurring of the entire disc margin. The optic disc of the fellow eye of the 2 patients with unilateral involvement was of normal colour and had normal-appearing vessels stemming from an average-sized cup. The vitreous, macular and peripheral retina were normal in both eyes of all patients. All study eyes demonstrated severe depression of their central visual field. CSF showed increased protein level and / or lymphocytes in 3 patients. No oligoclonal bands were found in any of the 6 patients undergoing CSF protein electrophoresis.
CT findings were normal in all patients. There were no areas of increased contrast uptake. MRI studies were done in 4 patients, 3 of whom had recurrent optic neuritis. No abnormal periventricular white matter signals were seen in any patient, although all four MRI studies demonstrated two or more high-intensity T2-weighted or FLAIR signals, > 3 mm in size, at the grey matter-white matter interface.
Response to steroid treatment and the clinical features at 3 or more months of follow-up are shown in Table 2 and reported in the text as two groups. Response to steroid treatment was considered significant if V A improved by 2 or more levels (e.g. LP to 3/60, or 1/60 to 6/60) within 72 h of commencing steroid treatment.
First-episode group (patients 1-6)
Six patients (10 eyes) had a single episode of optic neuritis. Follow-up ranged from 3 to 36 (median of 4, mean of 10) months. All patients received steroids (3 intravenous, 3 oral). Only 2 eyes (of the same patient) had a significant steroid response within 72 h. Over at least 3 months of follow-up, 4 eyes (right eye of patients 1 and 6, both eyes of patient 2) showed more than 3 levels of improvement in VA, 3 eyes recovered 6/12 or better vision, and only 2 regained good colour vision by Ishihara plate testing (� 10/13). All 4 of the improving eyes developed temporal pallor. The other 6 eyes in this group (left eye of patients 1 and 5, both eyes of patients 3 and 4) showed no improvement in visual function, and all went on to develop severe diffuse optic atrophy.
Recurrent group (patients 7-10)
Four patients (4 eyes) had recurrent optic neuritis. Follow-up of currently affected eyes ranged from 3 to 10 months. Total follow-up, from the initial episode of optic neuritis, ranged from 9 to 48 (mean of 32, median of 35) months. Patients 7 and 8 had multiple episodes of optic neuritis over a period of 3 years. Both patients had had severe unilateral optic neuritis of the right eye as their initial episode. Patient 9 had suffered severe unilateral optic neuritis of her left eye prior to the current episode. Patient 10 had suffered bilateral optic neuritis 13 months previously. Tables 1 and 2 record information pertaining to these patients' most recent attack of optic neuritis (boldface). All recurrences were in one eye only: the left eye of patients 7 and 8 and the right eye of patients 9 and 10. Note that in 3 of these 4 patients the currently unaffected fellow eye was blind with severe optic atrophy from previous optic neuritis. All 4 patients of this group received steroid treatment (3 intravenous, 1 oral). All had a significant response to steroids. Visual acuity improved by more than 3 levels in 3 patients and by 2 levels in the fourth. In 2 patients V A recovered to 6/12 or better. Two patients showed significant improvement in their Ishihara colour plate score. Six of the 8 affected eyes demonstrated diffuse, severe optic disc atrophy at follow-up.
Investigations for collagen vascular diseases were negative in all patients. Sarcoid screen (chest radiograph and serum ACE), ANA, RF and CRP were all within 
Discussion
This combined retrospective and prospective study describes 18 eyes of 10 black South African patients with acute isolated idiopathic optic neuritis (6 first-episode, 4 recurrent). We studied this specific clinical entity by excluding other causes of optic neuropathy (such as ION, toxins or Leber's), all causes of optic neuritis (such as HIV, neurosyphilis, sarcoid or connective tissue disease), neurological disease outside of the optic nerves and any race other than South African black.
Differentiating optic neuritis and ION is often difficult. In our study optic neuritis was differentiated from ION by the presence of pain on eye movement, the absence of vascular risk factors (ischaemic heart disease, hypertension, diabetes mellitus, hypercholesterolaemia and current smoking) and the relatively young age. Furthermore, 4 patients had recurrence, another 4 had bilateral simultaneous disease and all affected eyes demonstrated central and not altitudinal visual field defects. Unaffected contralateral eyes did not have crowded discs, typical of the 'disc at risk' for ION. In 2 patients in whom ION was considered a possibility (albeit an unlikely one), fundal fluorescein angiography was performed and was consistent with optic neuritis.
The first-episode patients had poorer recovery of visual function than the recurrent-episode patients and a much poorer visual outcome than the ONTT patients. 4
The recurrent group's initial episode of optic neuritis was their most severe. Patients 7, 8 and 9 suffered an initial severe attack on optic neuritis from which vision barely improved (LP or worse), whereas all 4 of the recently affected second eyes had substantial visual recovery. A similarity between the initial episode of optic neuritis in both the first-episode and the recurrent groups was noted: both had a very poor visual outcome, most eyes developed severe diffuse optic atrophy and the mean patient age was similar. The recurrent-episode patients were examined and followed by neurologists for a mean of 32 (median of 35) months. No other central nervous system signs or symptoms were found. Of the 3 patients who underwent MRI, none demonstrated abnormal periventricular signals, which is thought to be the MRI abnormality most specific for MS. 5 , 6 Three patients had CSF oligoclonal band testing, all with negative results. Allowing that recurrent optic neuritis (same or fellow eye) alone does not qualify as two sites, none of these 4 patients fulfilled the accepted criteria 7 for either clinical or laboratory supported MS.
Unfortunately only 4 study patients underwent MRI. 
